Tokyo, May 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061705) titled 'Study to investigate the effects of incretin drugs on depression, quality of life, and eating habits in Type 2 diabetes and obesity' on May 28.
Study Type:
Observational
Primary Sponsor:
Institute - Clinical Research Institute, National Hospital Organization Kyoto Medical Center
Condition:
Condition - Diabetes, Obesity
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - In diabetic and obese patients newly prescribed with incretins:
1. determine changes in treatment effect indicators (weight, glucose metabolism, etc.) after prescription
2. examine changes in depressio...